During the past decade, Brownstone Clinical Trials conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brownstone Clinical Trials" #1 sponsor was "Viamet" with 2 trials, followed by "Hologic, Inc." with 1 trials sponsored, "MethylGene Inc." with 1 trials sponsored, "Scynexis, Inc." with 1 trials sponsored and "TherapeuticsMD" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Brownstone Clinical Trials" are "Candida Vulvovaginitis" (1 trials), "Candidiasis, Vulvovaginal" (1 trials), "Chlamydia Trachomatis" (1 trials), "Gonorrhea" (1 trials) and "Menopause" (1 trials). Many other conditions were trialed in "Brownstone Clinical Trials" in a lesser frequency.

Most popular intervention types in "Brownstone Clinical Trials" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "VT-1161" (2 trials), "Estradiol" (1 trials), "Fluconazole" (1 trials) and "Ibrexafungerp" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brownstone Clinical Trials" are 6 trials for "Female" genders.

Currently, there are NaN active trials in "Brownstone Clinical Trials". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Brownstone Clinical Trials, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Brownstone Clinical Trials, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".